Analisis Pengaruh Vaksin Covid-19 Terhadap Nilai HbA1c Pasien DM Tipe-2 Di Puskesmas: Studi Retrospektive
- Intan Wiji Setyaningsih Universitas Harapan Bangsa, Purwokerto, Indonesia
-
Khamdiyah Indah Kurniasih
*
Universitas Harapan Bangsa, Purwokerto,
Indonesia
- Siti Setianingsih Universitas Harapan Bangsa, Purwokerto, Indonesia (*) Corresponding Author
Abstract
Coronavirus Disease 2019 (Covid-19) is a dangerous type of infection that causes death and is at risk in DM patients, so the selection of vaccines is very selective, especially moderna or pfizer vaccines that will know the increase in blood glucose. The purpose of this study was to determine the description and relationship of HbA1c values in type 2 DM patients after the 2nd dose of moderna or pfizer Covid-19 vaccine at Mrebet Health Center. The method used was analytical research with a retrospective observational approach conducted by conducting interviews with DM patients in the form of compliance with drug use, remaining drug use in 1 month, and sugar diet. Measurement of HbA1c values obtained from 3 months before and 3 months after the 2nd dose of moderna or pfizer vaccine. The results of the study obtained 32 DM prolanis patients, where the most patients were aged 45 - 65 years as many as 28 (87.5%), and female gender 27 (84.4%). The type of vaccine obtained was 25 (78.1%) moderna vaccine and 7 (21.9%) pfizer vaccine. The average pre-vaccine and post-vaccine HbA1c values increased by 0.3% from 8.0% to 8.3% and a standard deviation of 0.10. Based on the analysis, the p-value of 0.000 <0.050 was obtained, so statistically there was a slight increase with almost the same value between HbA1c values in type 2 DM patients after the Covid-19 moderna vaccine or the 2nd dose of pfizer. Conclusion There is an increase between pre-vaccine and post-vaccine HbA1c values and there is a relationship between HbA1c values in patients with type 2 DM after the Covid-19 moderna or pfizer 2nd dose vaccine.
Downloads
References
Akmal, M., Patel, P., & Wadhwa, R. (2024). Inhibitor Alfa Glukosidase. https://www.ncbi.nlm.nih.gov/books/NBK557848/
Al-Ozairi, E., Irshad, M., Taghadom, E., Varghese, A., Sojan, L., & Alkandari, J. (2023). Effect of COVID-19 vaccine on blood glucose metrics in Arabic people with type 1 diabetes. Frontiers in Endocrinology, 14(March), 1–7. https://doi.org/10.3389/fendo.2023.1120384
Albitar, O., Ballouze, R., Ping, J., Maisharah, S., & Ghadzi, S. (2020). Risk factors for mortality among COVID-19 patients. January.
AndraFarm. (2023). Covid-19. https://m.andrafarm.com/_andra.php?_i=daftar-co19-cari&jobs=purbalingga#posisiurut
Azrimadaliza, A., Annisa, A., & Rita, R. S. (2022). Faktor-faktor yang Berhubungan dengan Kadar HbA1c Anggota Klub Prolanis Diabetes Mellitus Tipe 2. Jurnal Ilmu Kesehatan Masyarakat, 11(01), 75–83. https://doi.org/10.33221/jikm.v11i01.991
Disperakim. (2021). 34 Kabupaten di Jateng Masuk 50 Besar Nasional Tertinggi Capaian Vaksin Covid-19. https://disperakim.jatengprov.go.id/berita/detail/186
Ekasari, E., & Dhanny, D. R. (2022). Faktor Yang Mempengaruhi Kadar Glukosa Darah Penderita Diabetes Melitus Tipe Ii Usia 46-65 Tahun Di Kabupaten Wakatobi. Journal of Nutrition College, 11(2), 154–162. https://doi.org/10.14710/jnc.v11i2.32881
Hanefeld, M. (1998). The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. Journal of Diabetes and Its Complications, 12(4), 228–237. https://doi.org/10.1016/S1056-8727(97)00123-2
He, Y.-F., Ouyang, J., Hu, X.-D., Wu, N., Jiang, Z.-G., Bian, N., & Wang, J. (2023). Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review. World Journal of Diabetes, 14(6), 892–918. https://doi.org/10.4239/wjd.v14.i6.892
Isnaini, N., & Ratnasari, R. (2018). Faktor risiko mempengaruhi kejadian Diabetes mellitus tipe dua. Jurnal Kebidanan Dan Keperawatan Aisyiyah, 14(1), 59–68. https://doi.org/10.31101/jkk.550
Kartono, T. H., Setiawan, D., Astuti, I. Y., & Farmasi, F. (2020). The Analysis of the Compliance of Taking Anti-Diabetic Medication against Fasting Blood Sugar Levels and Hba1c Value in Diabetes Mellitus Patients. Journal of Pharmacopolium, 3(3), 166–173.
Kemenkes RI. (2020). Keputusan Menteri Kesehatan RI No. HK.01.07/MENKES/9860/2020 Tentang Penetapan Jenis Vaksin Untuk Pelaksanaan Vaksinasi Coronavirus Disease 2019 (COVID-19). In Kemenkes RI (p. 4).
Kemenkes RI. (2023). PEMANTAUAN KASUS COVID-19 INDONESIA. Kementerian Kesehatan Republik Indonesia. https://pusatkrisis.kemkes.go.id/covid-19-id/
Kurniawati, T., Lestari, D., Rahayu, A. P., Syaputri, F. N., & Tugon, D. T. A. (2021). Evaluasi Profil Penggunaan Obat Antidiabetes Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan di Salah Satu Rumah Sakit Kabupaten Bogor. Jste, 3(1), 24–34. http://www.ejournal.umbandung.ac.id/index.php/jste
Lamb, Y. N. (2021). BNT162b2 mRNA COVID-19 Vaccine: First Approval. Drugs, 81(4), 495–501. https://doi.org/10.1007/s40265-021-01480-7
Li, R., Shen, M., Yang, Q., Fairley, C. K., Chai, Z., McIntyre, R., Ong, J. J., Liu, H., Lu, P., Hu, W., Zou, Z., Li, Z., He, S., Zhuang, G., & Zhang, L. (2023). Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19–Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care, 46(4), 890–897. https://doi.org/10.2337/dc22-1943
Lin, C. W., Hung, S. Y., & Chen, I. W. (2023). A study of glycemic perturbations following two doses of COVID-19 vaccination for patients with diabetes: the impacts of vaccine type and anti-diabetes drugs. Diabetology and Metabolic Syndrome, 15(1), 1–8. https://doi.org/10.1186/s13098-023-01059-0
Liu, J., Wang, J., Xu, J., Xia, H., Wang, Y., Zhang, C., Chen, W., Zhang, H., Liu, Q., Zhu, R., Shi, Y., Shen, Z., Xing, Z., Gao, W., Zhou, L., Shao, J., Shi, J., Yang, X., Deng, Y., … Liu, Z. (2021). Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell Discovery, 7(1). https://doi.org/10.1038/s41421-021-00329-3
Maimunah, S., Asrinawaty, & Rahman, E. (2020). Pengaruh Faktor Aktifitas Fisik, Genetik dan Pola Makan Terhadap Kejadian Diabetes Militus Type II Di RSUD Dr. H. Moch Ansari Saleh Banjarmasin Tahun 2020. EPrints UNISKA, 1, 1–10. http://eprints.uniska-bjm.ac.id/id/eprint/3130
Majumder, J., & Minko, T. (2021). Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS Journal, 23(1). https://doi.org/10.1208/s12248-020-00532-2
Melani, R., Kurniasih, K. I., & Fauziah. (2023). Analisis penggunaan antidiabetik dan antihipertensi pada pasien diabetes komorbid hipertensi di Puskesmas Mrebet. Journal of Pharmaceutical and Sciences, 1, 331–338.
Meo, S. A., Bukhari, I. A., Akram, J., Meo, A. S., & Klonoff, D. C. (2021). COVID-19 vaccines: Comparison of biological, pharmacological characteristics and adverse effects of pfizer/BioNTech and moderna vaccines. European Review for Medical and Pharmacological Sciences, 25(3), 1663–1679. https://doi.org/10.26355/eurrev_202102_24877
Naba, O. S., Adu, A. A., & Tedju Hinga, I. A. (2021). Gambaran Karakteristik Pasien Diabetes Melitus di Wilayah Kerja Puskesmas Sikumana Kota Kupang. Media Kesehatan Masyarakat, 3(2), 186–194. https://doi.org/10.35508/mkm.v3i2.3468
Pratama, I. P. Y., & Ratnasari, P. M. D. (2021). Pola Penggunaan Obat Pada Pasien Diabetes Melitus Tipe Ii Dengan Komplikasi Neuropati Pada Salah Satu Rumah Sakit Swasta Denpasar Bali. Acta Holistica Pharmaciana, 3(2), 30–37.
Rahayu, R. nani, & Sensusiyati. (2021). VAKSIN COVID 19 DI INDONESIA : ANALISIS BERITA HOAX. Intelektiva : Jurnal Ekonomi, Sosial & Humaniora Vaksin, 2(07), 11.
Romadhon, R., Saibi, Y., & Nasir, N. M. (2020). Kepatuhan Terhadap Pengobatan Pasien Diabetes Melitus Tipe 2 di Puskesmas Jakarta Timur. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 6(1), 94–103. https://doi.org/10.22487/j24428744.2020.v6.i1.15002
Samuel, S. M., Varghese, E., Triggle, C. R., & Büsselberg, D. (2022). COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance? Vaccines, 10(3), 1–9. https://doi.org/10.3390/vaccines10030454
Vasilev, G., Kabakchieva, P., Miteva, D., Batselova, H., & Velikova, T. (2022). Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World Journal of Diabetes, 13(9), 738–751. https://doi.org/10.4239/wjd.v13.i9.738
WHO. (2023). Data Perseberan Covid-19. https://covid19.go.id/id
Winaningsih, W., Setyowati, S., & Lestari, N. T. (2020). Aplikasi nutri diabetic care sebagai media konseling untuk meningkatkan kepatuhan diet diabetes mellitus. Ilmu Gizi Indonesia, 3(2), 103. https://doi.org/10.35842/ilgi.v3i2.134
Yan, H., Yang, W., Zhou, F., Li, X., Pan, Q., Shen, Z., Han, G., Newell-Fugate, A., Tian, Y., Majeti, R., Liu, W., Xu, Y., Wu, C., Allred, K., Allred, C., Sun, Y., & Guo, S. (2019). Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1. Diabetes, 68(2), 291–304. https://doi.org/10.2337/db18-0638
Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019). Advances in mRNA vaccines for infectious diseases. Frontiers in Immunology, 10(MAR), 1–13. https://doi.org/10.3389/fimmu.2019.00594
Bila bermanfaat silahkan share artikel ini
Berikan Komentar Anda terhadap artikel Analisis Pengaruh Vaksin Covid-19 Terhadap Nilai HbA1c Pasien DM Tipe-2 Di Puskesmas: Studi Retrospektive
Pages: 17-24
Copyright (c) 2024 Khamdiyah Indah Kurniasih
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (Refer to The Effect of Open Access).
